Karasuno T - Search Results

1

Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma.

Takakuwa T, Ohta K, Nakatani E, Ito T, Kaneko H, Fuchida SI, Shimura Y, Yagi H, Shibayama H, Kanda J, Uchiyama H, Kosugi S, Tanaka H, Kawata E, Uoshima N, Ishikawa J, Shibano M, Karasuno T, Shindo M, Shimizu Y, Imada K, Kanakura Y, Kuroda J, Hino M, Nomura S, Takaori-Kondo A, Shimazaki C, Matsumura I. Takakuwa T, et al. Among authors: karasuno t. Hematol Oncol. 2021 Aug;39(3):349-357. doi: 10.1002/hon.2863. Epub 2021 Mar 28. Hematol Oncol. 2021. PMID: 33724498 Clinical Trial.

2

Aberrant expression of immunoglobulin light chain isotype in B lymphocytes from patients with monoclonal gammopathies: isotypic discordance and clonal B-cell excess.

Oritani K, Katagiri S, Tominaga N, Iida M, Amano T, Karasuno T, Matsumura I, Mitsui H, Kanayama Y, Yonezawa T, et al. Oritani K, et al. Among authors: karasuno t. Br J Haematol. 1990 May;75(1):10-5. doi: 10.1111/j.1365-2141.1990.tb02610.x. Br J Haematol. 1990. PMID: 2115808

3

Functional role of cation-independent mannose 6-phosphate/insulin-like growth factor II receptor in cell adhesion and proliferation of a human myeloma cell line OPM-2.

Nishiura T, Karasuno T, Yoshida H, Nakao H, Ogawa M, Horikawa Y, Yoshimura M, Okajima Y, Kanakura Y, Kanayama Y, Matsuzawa Y. Nishiura T, et al. Among authors: karasuno t. Blood. 1996 Nov 1;88(9):3546-54. Blood. 1996. PMID: 8896422 Free article.

4

Effect of the interaction between fibronectin and VLA-4 on the proliferation of human B cells, especially a novel human B-cell line, OPM-3.

Yoshida H, Nishiura T, Karasuno T, Matsumura I, Ishikawa J, Yoshimura M, Yokota T, Okajima Y, Ogawa M, Kanakura Y, Tomiyama Y, Matsuzawa Y. Yoshida H, et al. Among authors: karasuno t. Br J Haematol. 1998 Dec;103(3):804-12. doi: 10.1046/j.1365-2141.1998.01049.x. Br J Haematol. 1998. PMID: 9858236 Free article.

5

Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma.

Nozaki K, Sugahara H, Ueda S, Ishikawa J, Fuji S, Masaie H, Tada Y, Karasuno T, Iida M, Mitsui H, Kamae T, Saito N, Moriyama Y, Kawakami M, Kato R, Nakae Y, Kida T, Kosugi S, Nakagawa M, Uchida Y, Azenishi Y, Sakaniwa R, Kitamura T, Shibayama H. Nozaki K, et al. Among authors: karasuno t. Leuk Lymphoma. 2020 Sep;61(9):2113-2121. doi: 10.1080/10428194.2020.1759054. Epub 2020 May 4. Leuk Lymphoma. 2020. PMID: 32366194

6

A multi-center retrospective analysis of patients with relapsed/refractory follicular lymphoma after third-line chemotherapy.

Fuji S, Tada Y, Nozaki K, Saito H, Ozawa T, Kida T, Kosugi S, Sugahara H, Ikeda H, Hashimoto K, Karasuno T, Ueda S, Ishikawa J, Shibayama H. Fuji S, et al. Among authors: karasuno t. Ann Hematol. 2020 Sep;99(9):2133-2139. doi: 10.1007/s00277-020-04126-y. Epub 2020 Jun 12. Ann Hematol. 2020. PMID: 32533251

7

Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.

Nakaya A, Tanaka H, Yagi H, Ohta K, Shibayama H, Kohara T, Kanda J, Shindo M, Shimura Y, Kosugi S, Kida T, Kaneko H, Imada K, Karasuno T, Matsuda M, Iida M, Adachi Y, Fuchida SI, Uoshima N, Uchiyama H, Takahashi R, Matsui T, Wada K, Kiyota M, Shimazaki C, Hino M, Kuroda J, Kanakura Y, Takaori-Kondo A, Nomura S, Matsumura I; Kansai Myeloma Forum Investigators. Nakaya A, et al. Among authors: karasuno t. Int J Hematol. 2020 Nov;112(5):666-673. doi: 10.1007/s12185-020-02961-3. Epub 2020 Aug 11. Int J Hematol. 2020. PMID: 32783165

8

Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden.

Nozaki K, Sugahara H, Ueda S, Ishikawa J, Karasuno T, Iida M, Kamae T, Moriyama Y, Kawakami M, Kosugi S, Nakagawa M, Azenishi Y, Sakaniwa R, Kitamura T, Shibayama H. Nozaki K, et al. Among authors: karasuno t. Int J Hematol. 2021 Aug;114(2):217-221. doi: 10.1007/s12185-021-03151-5. Epub 2021 Apr 13. Int J Hematol. 2021. PMID: 33847924

9

Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis.

Suzuki K, Mizuno S, Shimazu Y, Fuchida SI, Hagiwara S, Itagaki M, Nishiwaki K, Hangaishi A, Karasuno T, Kikuchi T, Shimizu M, Nishikawa A, Kobayashi T, Sunami K, Hiramoto N, Uchiyama H, Maruyama Y, Kanda Y, Ichinohe T, Atsuta Y, Yano S, Kawamura K; Working Group of the Japan Society; for Transplantation and Cellular Therapy. Suzuki K, et al. Among authors: karasuno t. Eur J Haematol. 2023 Apr;110(4):444-454. doi: 10.1111/ejh.13922. Epub 2023 Jan 17. Eur J Haematol. 2023. PMID: 36597575

10

Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum.

Shimura Y, Shibayama H, Nakaya A, Yamamura R, Imada K, Kaneko H, Hanamoto H, Fuchida SI, Tanaka H, Kosugi S, Kiyota M, Matsui T, Kanda J, Iida M, Matsuda M, Uoshima N, Shibano M, Karasuno T, Hamada T, Ohta K, Ito T, Yagi H, Yoshihara S, Shimazaki C, Nomura S, Hino M, Takaori-Kondo A, Matsumura I, Kanakura Y, Kuroda J. Shimura Y, et al. Among authors: karasuno t. Int J Hematol. 2023 Nov;118(5):609-617. doi: 10.1007/s12185-023-03653-4. Epub 2023 Sep 5. Int J Hematol. 2023. PMID: 37668833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters